Leon Recanati

Mr. Leon Y. Recanati has served as Evogene director since 2005. Mr. Recanati has served as chairman and chief executive officer of GlenRock Israel Ltd., his private investment company, investing since 2003 in Venture Capital and private equity companies. Previously, Mr. Recanati was chief executive officer and/or chairman of IDB Holding Corporation; Clal Industries Ltd.; Azorim Investment Development and Construction Co Ltd.; Delek Israel Fuel Corporation; and Super-Sol Ltd. He also founded Clal Biotechnologies Industries Ltd., a biotechnology investment company operating in Israel.

Mr. Recanati is a member of the board of directors of Kamada Ltd. ,of Rainbow Medical and active in education and health endeavors through several NGO’s .

Mr. Recanati holds an MBA from the Hebrew University of Jerusalem and Honorary Doctorates from the Technion Institute of Technology and Tel Aviv University.